Insulet Stock Performance
| PODD Stock | USD 262.00 4.58 1.72% |
On a scale of 0 to 100, Insulet holds a performance score of 23. The company retains a Market Volatility (i.e., Beta) of 0.21, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Insulet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Insulet is expected to be smaller as well. Please check Insulet's skewness, day typical price, and the relationship between the downside variance and daily balance of power , to make a quick decision on whether Insulet's current trending patterns will revert.
Risk-Adjusted Performance
23 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Insulet are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Insulet exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.58) | Five Day Return 1.54 | Year To Date Return 26.74 | Ten Year Return 485.57 | All Time Return 1.6 K |
1 | Disposition of 1506 shares by Lauren Budden of Insulet at 221.41 subject to Rule 16b-3 | 09/06/2024 |
2 | Insulet Corp Q2 2024 Earnings Call Highlights Strong Revenue Growth and Raised Guidance | 10/09/2024 |
3 | KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusio... | 10/31/2024 |
4 | Insulet Non-GAAP EPS of 0.90 beats by 0.14, revenue of 543.9M beats by 24.62M | 11/07/2024 |
5 | Citi lifts Insulet shares target on strong Q3 results | 11/08/2024 |
6 | Sheets Smith Wealth Management Invests 233,000 in Insulet Co. | 11/11/2024 |
7 | Disposition of 508 shares by Borio Luciana of Insulet at 274.8 subject to Rule 16b-3 | 11/12/2024 |
8 | Capital Research Global Investors Expands Stake in Insulet Corp | 11/13/2024 |
9 | Polar Asset Management Partners Inc. Acquires New Stake in EQV Ventures Acquisition Corp | 11/15/2024 |
10 | Insulets Omnipod 5 now compatible with Abbotts FreeStyle Libre 2 Plus | 11/20/2024 |
| Begin Period Cash Flow | 689.7 M |
Insulet |
Insulet Relative Risk vs. Return Landscape
If you would invest 18,069 in Insulet on August 24, 2024 and sell it today you would earn a total of 8,131 from holding Insulet or generate 45.0% return on investment over 90 days. Insulet is currently generating 0.611% in daily expected returns and assumes 2.0195% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Insulet, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Insulet Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insulet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insulet, and traders can use it to determine the average amount a Insulet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.3025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PODD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.02 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.3 actual daily | 23 77% of assets perform better |
Based on monthly moving average Insulet is performing at about 23% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insulet by adding it to a well-diversified portfolio.
Insulet Fundamentals Growth
Insulet Stock prices reflect investors' perceptions of the future prospects and financial health of Insulet, and Insulet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insulet Stock performance.
| Return On Equity | 0.49 | ||||
| Return On Asset | 0.0757 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 18.87 B | ||||
| Shares Outstanding | 70.14 M | ||||
| Price To Book | 16.44 X | ||||
| Price To Sales | 9.43 X | ||||
| Revenue | 1.7 B | ||||
| Gross Profit | 805.6 M | ||||
| EBITDA | 323.6 M | ||||
| Net Income | 206.3 M | ||||
| Cash And Equivalents | 708.6 M | ||||
| Cash Per Share | 10.21 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.69 X | ||||
| Book Value Per Share | 15.94 X | ||||
| Cash Flow From Operations | 145.7 M | ||||
| Earnings Per Share | 5.87 X | ||||
| Market Capitalization | 18.7 B | ||||
| Total Asset | 2.59 B | ||||
| Retained Earnings | (378 M) | ||||
| Working Capital | 1.13 B | ||||
| Current Asset | 190.76 M | ||||
| Current Liabilities | 65.16 M | ||||
About Insulet Performance
By analyzing Insulet's fundamental ratios, stakeholders can gain valuable insights into Insulet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Insulet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Insulet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 273.55 | 287.22 | |
| Return On Tangible Assets | 0.08 | 0.09 | |
| Return On Capital Employed | 0.10 | 0.11 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.28 | 0.30 |
Things to note about Insulet performance evaluation
Checking the ongoing alerts about Insulet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insulet help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Insulets Omnipod 5 now compatible with Abbotts FreeStyle Libre 2 Plus |
- Analyzing Insulet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insulet's stock is overvalued or undervalued compared to its peers.
- Examining Insulet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insulet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insulet's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Insulet's stock. These opinions can provide insight into Insulet's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |